GE Healthcare’s somo•v INSIGHT System was recognized as the category leader with the highest ranking in Women’s Imaging (Specialty) in the 2013 Best in KLAS Awards: Medical Equipment & Infrastructure Report. The Best in KLAS Awards Report ranked imaging, pharmacy automation and infrastructure vendors. This year, over 180 products were ranked by healthcare providers.
KLAS, an independent research firm, monitors vendor performance through the active participation of thousands of healthcare organizations. KLAS Performance Data represents the opinions of healthcare executives, managers, and clinicians from over 4,500 hospitals and 2,500 clinics, who have rated over 750 products and services from more than 200 vendors.
Using proprietary technology to automate the ultrasound imaging process, the somo•v ABUS system was developed specifically for the breast cancer screening environment. Demonstrating a 35.7 percent improvement in cancer detection (sensitivity), the somo•v ABUS system is the only ultrasound device approved for breast cancer screening in the United States as an adjunct to mammography for asymptomatic women with dense breast tissue who have not had prior breast intervention.
“Our commitment to ABUS technology and making it available to more healthcare providers and patients around the world is a reflection of the company’s efforts in tackling breast cancer and our overall $1B investment to advance oncology solutions by 2016,” said Anders Wold, President and CEO of GE Ultrasound.